January 1, 2021 – Reference in Science Magazine

Updated: Mar 3, 2022

Research undertaken by Dr. Smith on an antisense oligonucleotide clinical trial, published in Lancet Neurology in 2013, was referenced in an article in Science titled "RNA-targeted drugs for neuromuscular diseases" (Vol. 371, Issue 6524, pp. 29-31).

Recent Posts

The title of his talk is " Seed-Amplification Assays: Windows into ALS and Kindred Diseases".

Qualsody/Toferson conceived by CNS Director Dr. Smith and developed in collaboration with Don Cleveland (UCSD), Tim Miller (WashU), and...

The open access version of "Chinese Translation and Validation of the Center for Neurologic Study Lability Scale" has been published in...